BioLife Solutions, Inc. (BLFS) |
|
14.64 0.83 (6.01%)
|
07-02 16:45 |
|
Open: |
13.67 |
Pre. Close: |
13.81 |
|
High:
|
14.76 |
Low:
|
13.67 |
|
Volume:
|
351,360 |
Market Cap:
|
621(M) |
|
|
|
|
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
14.79 - 14.89 |
14.89 - 14.98 |
|
Low:
|
13.44 - 13.56 |
13.56 - 13.67 |
|
Close:
|
14.45 - 14.64 |
14.64 - 14.82 |
|
Technical analysis |
as of: 2022-07-01 4:20:28 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, upgraded from strong sell. Downward movement continues, but could change at any time. |
| Target: |
Six months: 19.3 One year: 22.55 |
| Support: |
Support1: 14.1 Support2: 12.6 |
| Resistance: |
Resistance1: 16.53 Resistance2: 19.3 |
| Pivot: |
14.22 |
| Moving Average: |
MA(5): 14.51  MA(20): 14.24
MA(100): 17.75 MA(250): 32.71 |
| MACD: |
MACD(12,26): 0.2 Signal(9): 0.1 |
| Stochastic oscillator: |
%K(14,3): 44.1 %D(3): 47.4 |
| RSI: |
RSI(14): 52.8 |
| 52-week: |
High: 60.66 Low: 10.39 |
| Average Vol(K): |
3-Month: 509 (K) 10-Days: 659 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ BLFS ] has closed below upper band by 37.2%. Bollinger Bands are 40.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 17 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Thu, 30 Jun 2022
Insider Selling: BioLife Solutions, Inc. (NASDAQ:BLFS) EVP Sells 704 Shares of Stock - MarketBeat
Thu, 30 Jun 2022
12900 Shares in BioLife Solutions, Inc. (NASDAQ:BLFS) Acquired by NorthCrest Asset Manangement LLC - Defense World
Mon, 27 Jun 2022
Billionaire Israel Englander Pulls the Trigger on These 2 “Strong Buy” Stocks - TipRanks
Sun, 19 Jun 2022
BioLife Solutions, Inc. (NASDAQ:BLFS) Given Consensus Rating of “Buy” by Analysts - Defense World
Thu, 09 Jun 2022
BioLife Solutions Deploys SciSafe's Ultra Low Controlled Temperature Trailers to Extend Domestic Cold Chain Services - PR Newswire
Wed, 08 Jun 2022
BioLife Solutions, Inc. (NASDAQ:BLFS) Expected to Post Earnings of -$0.20 Per Share - MarketBeat
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Instruments & Supplies |
| Shares Out. |
42 (M) |
| Shares Float |
31 (M) |
|
% Held by Insiders
|
7.2 (%) |
|
% Held by Institutions
|
84.7 (%) |
|
Shares Short
|
1,260 (K) |
|
Shares Short P.Month
|
1,040 (K) |
Stock Financials |
|
EPS
|
0.12 |
|
EPS Est Next Qtl
|
-0.06 |
|
EPS Est This Year
|
-0.24 |
|
EPS Est Next Year
|
-0.06 |
|
Book Value (p.s.)
|
11.81 |
|
Profit Margin (%)
|
-6.5 |
|
Operating Margin (%)
|
-23.8 |
|
Return on Assets (ttm)
|
-4.5 |
|
Return on Equity (ttm)
|
-2.3 |
|
Qtrly Rev. Growth
|
153.3 |
|
Gross Profit (p.s.)
|
0.91 |
|
Sales Per Share
|
2.86 |
|
EBITDA (p.s.)
|
-0.38 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-5 (M) |
|
Levered Free Cash Flow
|
-15 (M) |
Stock Valuations |
|
PE Ratio
|
112.61 |
|
PEG Ratio
|
-1.6 |
|
Price to Book value
|
1.23 |
|
Price to Sales
|
5.11 |
|
Price to Cash Flow
|
-132.85 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
